Filing Details

Accession Number:
0001493152-22-036060
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-20 21:02:35
Reporting Period:
2022-12-20
Accepted Time:
2022-12-20 21:02:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610820 Briacell Therapeutics Corp. BCTX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1942516 Jamieson Bondarenko C/O Briacell Therapeutics Corp.
235 15Th Street,Suite 300
West Vancouver A1 V7T 2X1
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2022-12-20 22,000 $5.35 141,856 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct